Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Chisato Goto"'
Autor:
Taku Fukuzawa, Masanori Fukazawa, Otoya Ueda, Hideaki Shimada, Aki Kito, Mami Kakefuda, Yosuke Kawase, Naoko A Wada, Chisato Goto, Naoshi Fukushima, Kou-Ichi Jishage, Kiyofumi Honda, George L King, Yoshiki Kawabe
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e56681 (2013)
Although excessive fructose intake is epidemiologically linked with dyslipidemia, obesity, and diabetes, the mechanisms regulating plasma fructose are not well known. Cells transfected with sodium/glucose cotransporter 5 (SGLT5), which is expressed e
Externí odkaz:
https://doaj.org/article/c273d1438edf4164a6e71434670c0f05
Autor:
Yasunaga Iwasaki, Chisato Goto, Wataru Sugeno, Tadahisa Higashide, Dong-Hyuk Ahn, Mizuho Itoh
Publikováno v:
The Horticulture Journal. 89:417-424
Autor:
Mizuho Itoh, Yasunaga Iwasaki, Chisato Goto, Wataru Sugeno, Dong-Hyuk Ahn, Tadahisa Higashide
Publikováno v:
The Horticulture Journal. 89:403-409
Autor:
Manami Yusa, Masuyuki Takaichi, Yasunaga Iwasaki, Chisato Goto, Wataru Sugeno, Naoko Goto, Shiori Takayama, Iwao Takano, Hiroaki Yamane, Mizuho Ito, Yukiko Honnma
Publikováno v:
The Horticulture Journal. 88:13-20
Autor:
Hideto Kurosaki, Tomohiko Ota, Chisato Goto, Wataru Sugeno, Mizuho Ito, Yasunaga Iwasaki, Hiroaki Yamane
Publikováno v:
SC10201706140004
We developed a prototypic automatic spacing-controlled movable bench system for high-density planting of tomato third-truss pinching cultivation. The bench spacing can be changed to 600, 1000, or 1400 mm according to the growth stage. Cultivation exp
Autor:
Mizuho Noguchi, Tsuneo Ito, Etsuko Fujii, Takahiro Ishiguro, Kou-ichi Jishage, Yasuko Kinoshita, Hiromi Tateishi, Kiyoharu Sato, Hiroshi Hino, Kunihiro Hattori, Atsuhiko Kato, Otoya Ueda, Masahiro Morita, Jun-ichi Nezu, Chisato Goto, Kaoru Matsumoto, Yosuke Kawase, Naoko A. Wada, Mami Kakefuda
Publikováno v:
Scientific Reports. 8
Correction to: Scientific Reports 7: Article number: 45839; published online: 03 April 2017; updated: 19 March 2018 In this Article, the Authors neglected to include the Data and Material Availability section. This section should read: “Data and ma
Autor:
Hiroshi Hino, Etsuko Fujii, Jun-ichi Nezu, Tsuneo Ito, Kaoru Matsumoto, Takahiro Ishiguro, Yosuke Kawase, Hiromi Tateishi, Mizuho Noguchi, Yasuko Kinoshita, Kiyoharu Sato, Masahiro Morita, Naoko A. Wada, Mami Kakefuda, Kou-ichi Jishage, Chisato Goto, Otoya Ueda, Kunihiro Hattori, Atsuhiko Kato
Publikováno v:
Scientific Reports
T cell–mediated immunotherapy is an attractive strategy for treatment in various disease areas. In this therapeutic approach, the CD3 complex is one of the key molecules to modulate T cell functions; however, in many cases, we cannot evaluate the d
Autor:
Takeshi Matsubara, Kunihiko Nakahara, Otoya Ueda, Naoshi Fukushima, Hideharu Abe, Seiji Kishi, Kou-ichi Jishage, Toshio Doi, Tatsuya Tominaga, Toshikazu Araoka, Chisato Goto, Akira Mima, Taichi Murakami, Kojiro Nagai
Publikováno v:
Journal of Biological Chemistry. 286:20109-20116
Diabetic nephropathy (DN) is the most common cause of chronic kidney disease. We have previously reported that Smad1 transcriptionally regulates the expression of extracellular matrix (ECM) proteins in DN. However, little is known about the regulator
Autor:
Hidenori Arai, Kojiro Nagai, Masahiko Kinosaki, Noriyuki Iehara, Seiji Kishi, Chisato Goto, Hideharu Abe, Kou-ichi Jishage, Akira Mima, Toru Kita, Takeshi Matsubara, Makoto Araki, Otoya Ueda, Naoshi Fukushima, Toshio Doi, Tatsuya Tominaga
Publikováno v:
Diabetes. 64(8)
Diabetic nephropathy is the leading cause of end-stage renal disease. It is pathologically characterized by the accumulation of extracellular matrix in the mesangium, of which the main component is α1/α2 type IV collagen (Col4a1/a2). Recently, we i
Autor:
Takanori Tachibe, Otoya Ueda, Etsuko Fujii, Naoko A. Wada, Mami Kakefuda, Makoto Kawaharada, Yosuke Kawase, Shin Shimaoka, Kou-ichi Jishage, Hiromi Tateishi, Yoshinobu Higuchi, Kunihiro Hattori, Atsuhiko Kato, Chisato Goto
Publikováno v:
Scientific Reports
For clinical trials of therapeutic monoclonal antibodies (mAbs) to be successful, their efficacy needs to be adequately evaluated in preclinical experiments. However, in many cases it is difficult to evaluate the candidate mAbs using animal disease m